Filing Details

Accession Number:
0000721371-14-000086
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-05 18:27:22
Reporting Period:
2014-02-05
Filing Date:
2014-02-05
Accepted Time:
2014-02-05 18:27:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
721371 Cardinal Health Inc CAH Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 310958666
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1179497 B Gregory Kenny 7000 Cardinal Place
Dublin OH 43017
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2014-02-05 3,092 $48.92 22,676 No 4 M Direct
Common Shares Acquisiton 2014-02-05 5,282 $44.27 27,958 No 4 M Direct
Common Shares Acquisiton 2014-02-05 9,801 $28.80 37,759 No 4 M Direct
Common Shares Disposition 2014-02-05 18,175 $65.39 19,584 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Stock Option (right to buy) Disposition 2014-02-05 3,092 $0.00 3,092 $48.92
Common Shares Stock Option (right to buy) Disposition 2014-02-05 5,282 $0.00 5,282 $44.27
Common Shares Stock Option (right to buy) Disposition 2014-02-05 9,801 $0.00 9,801 $28.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-08-01 2014-08-01 No 4 M Direct
0 2008-11-07 2014-11-07 No 4 M Direct
0 2009-11-04 2015-11-05 No 4 M Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.34 to $65.44, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.